Ola A. Harb

658 total citations
61 papers, 462 citations indexed

About

Ola A. Harb is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ola A. Harb has authored 61 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Ola A. Harb's work include Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (6 papers) and Ferroptosis and cancer prognosis (5 papers). Ola A. Harb is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (6 papers) and Ferroptosis and cancer prognosis (5 papers). Ola A. Harb collaborates with scholars based in Egypt, Saudi Arabia and United Kingdom. Ola A. Harb's co-authors include Sameh Abdelaziz Aly, Mohammad Abd Alkhalik Basha, Mohamed Zaitoun, Mohamed Ali Alabiad, Safaa A. Ibrahim, Abdulwahab Abuderman, Amany Mohamed Shalaby, Ghada Fathy, Amr Shaaban Hanafy and Omar Hussein and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Ola A. Harb

54 papers receiving 458 citations

Peers

Ola A. Harb
Zoltán Hernádi Hungary
Francesco Battaglia Italy
Yuya Nogami Japan
Dan Beck Israel
Michael A. Bidus United States
Huijuan Ge China
Patricia Luhn United States
Ce Bian China
Hyung Bae Moon South Korea
Alberto Villanueva Spain
Zoltán Hernádi Hungary
Ola A. Harb
Citations per year, relative to Ola A. Harb Ola A. Harb (= 1×) peers Zoltán Hernádi

Countries citing papers authored by Ola A. Harb

Since Specialization
Citations

This map shows the geographic impact of Ola A. Harb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola A. Harb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola A. Harb more than expected).

Fields of papers citing papers by Ola A. Harb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola A. Harb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola A. Harb. The network helps show where Ola A. Harb may publish in the future.

Co-authorship network of co-authors of Ola A. Harb

This figure shows the co-authorship network connecting the top 25 collaborators of Ola A. Harb. A scholar is included among the top collaborators of Ola A. Harb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola A. Harb. Ola A. Harb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sharaf, Ahmed, et al.. (2023). Synchronous occurrence of primary mucinous carcinoma of recto-sigmoid colon and primary breast Carcinoma: A case report and review of literature. SHILAP Revista de lepidopterología. 32. 300702–300702. 1 indexed citations
3.
Sharaf, Ahmed, et al.. (2023). Pregnancy after bariatric surgeries; best time, gestational, and neonatal outcomes. Middle East Fertility Society Journal. 28(1). 4 indexed citations
4.
Sharaf, Ahmed, et al.. (2023). Risk Factors and Outcomes of Occurrence of Anastomotic Leakage and Reoperations for its Management after Colorectal Surgery. SHILAP Revista de lepidopterología. 43(2). 82–92.
5.
Harb, Ola A., et al.. (2022). Antimullerian Hormone Levels and Association with Abortion and Preterm Delivery in Patients with Polycystic Ovary Syndrome Who Conceived with Assisted Reproductive Techniques. The Journal of Obstetrics and Gynecology of India. 72(S1). 295–298. 2 indexed citations
6.
7.
Harb, Ola A., et al.. (2021). Prognostic and Clinicopathological Implications of NUSAP1, MELK and L1CAM Immunohistochemical Expression in Cervical Cancer. SHILAP Revista de lepidopterología. 12(2). 172–182. 1 indexed citations
8.
Aly, Sameh Abdelaziz, et al.. (2021). The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study. European Radiology. 31(9). 6949–6961. 52 indexed citations
9.
10.
11.
12.
Basha, Mohammad Abd Alkhalik, et al.. (2020). Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses. European Radiology. 31(2). 674–684. 85 indexed citations
13.
Abuderman, Abdulwahab, et al.. (2020). TFAP2B, AP-1 and JAZF1 Expression in Tissues of Papillary Thyroid Carcinoma Patients; Clinical, Pathological and Prognostic Values. Asian Pacific Journal of Cancer Prevention. 21(8). 2415–2421. 5 indexed citations
14.
Abuderman, Abdulwahab, et al.. (2020). Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study. Współczesna Onkologia. 24(2). 87–95. 5 indexed citations
15.
16.
Basha, Mohammad Abd Alkhalik, et al.. (2019). The validity and reproducibility of the thyroid imaging reporting and data system (TI-RADS) in categorization of thyroid nodules: Multicentre prospective study. European Journal of Radiology. 117. 184–192. 39 indexed citations
17.
Fathy, Ghada, et al.. (2017). Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni : A novel insight. Experimental Parasitology. 183. 23–32. 13 indexed citations
18.
Harb, Ola A., et al.. (2017). The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma. Journal of Oncology. 2017. 1–9. 6 indexed citations
19.
Harb, Ola A.. (2017). Value of CD56, HBME-1, and CK19 Expression in Predicting the Risk of Papillary Thyroid Carcinoma (PTC) Occurrence in Hashimoto’s Thyroiditis (HT) Patients. Oncology Research and Treatment. 2(1). 1–9. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zoltán Hernádi Breakdown of academic impact, for papers by Francesco Battaglia Breakdown of academic impact, for papers by Yuya Nogami Breakdown of academic impact, for papers by Dan Beck Breakdown of academic impact, for papers by Michael A. Bidus Breakdown of academic impact, for papers by Huijuan Ge Breakdown of academic impact, for papers by Patricia Luhn Breakdown of academic impact, for papers by Ce Bian Breakdown of academic impact, for papers by Hyung Bae Moon Breakdown of academic impact, for papers by Alberto Villanueva
Rankless by CCL
2026